原发性肾病综合征患者胰岛素抵抗及肾组织ISNR-β、CPR、eNOS的表达-东南大学学报医学版

原发性肾病综合征患者胰岛素抵抗及肾组织ISNR-β、CPR、eNOS的表达

单位：重庆医科大学第一附属医院,肾内科,重庆,400016

分类号：R692

出版年·卷·期（页码）：2004·23·第五期（298-303）

摘要：

目的:探讨原发性肾病综合征患者是否存在胰岛素抵抗以及其发生机理和肾组织ISNR-β、CPR、eNOS的表达.方法:检测46例原发性肾病综合征患者和20例健康对照者空腹血清葡萄糖(FG)、空腹血清胰岛素(FISN)和空腹血清C-肽(FCP)水平,计算胰岛素敏感指数(ISI).分析ISI与血压、血脂、肾功能变化的关系.应用免疫组织化学法检测肾组织胰岛素受体β(ISNR-β)、C-肽受体(CPR)和内皮型一氧化氮合成酶(eNOS)的表达.结果:原发性肾病综合征患者FG、FISN、FCP的水平显著高于对照组,ISI显著低于对照组,且患者ISI的降低与甘油三酯、低密度脂蛋白、血尿酸的升高呈显著负相关.患者肾组织ISNR-β、CPR和eNOS的表达较对照肾组织无显著改变.结论:原发性肾病综合征患者存在血糖、胰岛素和C-肽水平的升高及胰岛素抵抗.其原因可能与血压升高、血脂和尿酸代谢紊乱等有关.患者肾组织ISNR-β、CPR和eNOS的表达无显著变化.

Objective To investigate insulin resistance (IR),its existent and its possible pathogenesis, the expression of insulin receptor beta(INSR、β),C、peptide receptor(CPR) and endothelial nitric oxide synthase(eNOS)in renal tissue in primary nephrotic syndrome patients.Methods Of all the patients and normal controls,fasting serum glucose(FG), insulin(FISN), C、peptide(FCP) were detected, insulin sensitive index(ISI) was calculated by the formula previously reported.The reported before. The relationship between ISI and blood lipid, ISI and renal function, were investigated. The expression of ISNR、β,CPR and eNOS in renal organism were detected by immunohistochemical staining technique. Results Compared with normal controls, the concentration of FG, FISN, FCP increased significantly(P<0.01 or P<0.05), and ISI decreased significantly(P<0.01)in primary nephrotic syndrome patients.Their ISI correlated negatively with triglyceride(TG) (P< 0.05),low density lipoprotein cholesterol(LDL、c)(P<0.05) and blood uric acid(UA)(P<0.01). While,the expressions of INSR、β,CPR and eNOS in renal organism had no statistical differences between patients and controls. Conclusion Primary nephrotic syndrome patients have insulin resistance and increased concentrations of blood glucose, insulin and C、peptide,the possible reasons for which are blood pressure rise, derangement of blood lipid and UA. While the expression of ISNR、β,CPR and eNOS in renal organism has no significant change in primary nephrotic syndrome patients.

参考文献：

[1] MAK R H, HAYCOCK G B, CHANTLER C. Glucose intolerance in children with chronic renal failure, 1983(zk)
[2] Flister D, PACINI G, ENGELLEITERr R. Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. 1998(5). doi:10.1046/j.1523-1755.1998.00898.x
[3] Duckworth W C. Insulin and glucagon binding and degradation by kidney cell membranes. 1978(6). doi:10.1210/endo-102-6-1766
[4] Rigler R, PRAMANIK A, JONASSON P. Specific binding of proinsulin C-peptide to human cell membranes. 1999(23). doi:10.1073/pnas.96.23.13318
[5] Michel T, FERON O. Nitric oxide synthases:which,where,how,and why. 1997(9). doi:10.1172/JCI119750
[6] Furusu A, MIYAZAKI M, ABE K. Expression of endothelial and inducible nitric oxide synthase in human glomerulonephritis. 1998(6). doi:10.1046/j.1523-1755.1998.00907.x
[7] Kuboki K, JIANG Z Y, TAKAHARA N. Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo:a specific vascular action of insulin, 2000
[8] Ido Y, VINDIGNI A, CHANG K. Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. 1997(5325). doi:10.1126/science.277.5325.563
[9] Johansson B L, BORG K, FERNQVIST-FORBES E. Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with type 1 diabetes:a three-month study. 2000(3). doi:10.1046/j.1464-5491.2000.00274.x
[10] SAMNEGARD B, JACOBSON S H, JAREMKO G. Effects of C-peptide on glomerular and renal size and renal function in diabetic rats. 2001(4). doi:10.1046/j.1523-1755.2001.00964.x
[11] Fery F, PLAT L, BALERIAUX M. Inhibition of lipolysis stimulates whole body glucose production and disposal in normal postabsorptive subjects. 1997(3)
[12] Unger R H, ZHOU Y T. Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover. 2001(ZK). doi:10.2337/diabetes.50.2007.S118
[13] Defronzo R A, BONADONNA R C, FERRANNINI E. Pathogenesis of NIDDM,a balanced overview. 1992(3). doi:10.2337/diacare.15.3.318
[14] 高维国, 石海燕, 董砚虎. 脂毒性与2型糖尿病的研究进展. 国外医学(内分泌学分册)2003(1). doi:10.3760/cma.j.issn.1673-4157.2003.01.026
[15] Ye J M, DOYLE P J, IGLESIAS M A. Peroxisome proliferator-activated receptor(PPAR)-α activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats:comparision with PPAR-γ activation. 2001(2). doi:10.2337/diabetes.50.2.411
[16] Vanitallie T B. Stress: a risk factor for serious illness. 2002(6 Suppl 1). doi:10.1053/meta.2002.33191
[17] Fasshauer M, KLEIN J, NEUMANN S. Adiponectin gene expression is inhibited by beta-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes. 2001. doi:10.1016/S0014-5793(1)02960-X
[18] DULLOO A G, JACQUET J, MONTANI J P. Pathways from weight fluctuations to metabolic diseases:focus on maladaptive thermogenesis during catch-up fat. 2002(Suppl 2). doi:10.1038/sj.ijo.0802127
[19] QUNINONES G A, NATALI A, BALDI S. Effect of insulin on uric acid excretion in humans, 1995
[20] RASIC-MILUTINOVIC Z, PERUNICIC-PEKORIC G, PIJESA S. Clinical significance and pathogenic mechanisms of insulin resistance in chronic renal insufficiency(part Ⅱ):pathogenic factors of insulin resistance in chronic renal insufficiency, 2000
[21] Nishimura M, HATAKEYAMA E, WAKABAYASHI Y. Role of tumor necrosis factor-alpha in insulin sensitivity and effect of low protein diet on the TNF-alpha response in patients with renal failure, 1997
[22] Steinberg H O, WU Y G, HOOK G. Insulin mediated nitric oxide production is impaired in insulin resistance, 1997(Z1)

服务与反馈：

【文章下载】【发表评论】【查看评论】【加入收藏】

提示：您还未登录，请登录！点此登录